eptifibatide [aapp, phsu]
Primary [qlco]
Syndromes, Acute Coronary [dsyn]
Thrombus [patf]
manifestation [ftcn]
Platelet aggregation [celf]
Part [spco]
Normal [qlco]
Process [bpoc]
Haemostasis [ortf]
Discovery [acty]
Final [tmco]
Step [cnce]
Platelet aggregation [celf]
binding [ftcn]
Fibrinogen [aapp, bacs, phsu]
Activated [acty]
Platelet glycoprotein IIb-IIIa [aapp]
Integrin [aapp, imft, rcpt]
Opened [spco]
Door [mnob]
Novel [tmco]
effective [qlco]
Therapies [topp]
abciximab [aapp, imft, phsu]
Human [humn]
Murine [mamm]
chimeric [orgm]
Fab Fragment [aapp, imft]
Monoclonal antibody [aapp, imft]
glycoprotein IIb IIIa receptor [aapp, imft, rcpt]
Agent [chvf]
Class [inpr]
Effectiveness [qlco]
Several [qnco]
Specific [qlco]
properties [qlco]
abciximab [aapp, imft, phsu]
Long [qlco]
Half-Life [tmco]
lack [qlco]
receptor [aapp, rcpt]
Blocking [mobd]
Specificity [qnco]
ANTIGENICITY [rnlw]
prompted [ftcn]
Alternative [cnce]
Glycoprotein IIb/IIIa [aapp, imft, rcpt]
inhibitors [chvf]
Pharmacologic [bmod]
Profile [lbpr]
Methods [inpr]
New Agents [clas]
eptifibatide [aapp, phsu]
Glycoprotein IIb/IIIa [aapp, imft, rcpt]
barbourin [bacs, hops]
Venom [hops]
Southeastern [spco]
Pygmy rattlesnake [rept]
eptifibatide [aapp, phsu]
Small [qnco]
Cyclic [tmco]
Specificity [qnco]
Affinity [npop]
Glycoprotein IIb/IIIa [aapp, imft, rcpt]
short [qlco]
Plasma [bdsu]
Half-Life [tmco]
Rapid onset [fndg]
Action [ftcn]
Rapid [qlco]
Reversibility [tmco]
Platelet [cell]
Inhibition [menp]
treatment [ftcn]
stopped [qlco]
Conclusions [idcn]
Clinical Trials [resa]
Culminating [qlco]
Phase [tmco]
III [inpr]
IMPACT [gngm]
Ii [aapp]
Integrelin [aapp, phsu]
Platelet aggregation [celf]
Coronary Thrombosis [dsyn]
Platelet glycoprotein IIb-IIIa [aapp]
Angina, Unstable [dsyn]
receptor [aapp, rcpt]
Suppression [patf]
Integrelin [aapp, phsu]
therapy [ftcn]
Trial [resa]
eptifibatide [aapp, phsu]
coronary [bpoc]
Events [evnt]
Broad [spco]
Range [qnco]
Medium [inpr]
High Risk [qlco]
Patients [podg]
Syndromes, Acute Coronary [dsyn]
Increasing [ftcn]
Bleeding [patf]
Complications [patf]
Suggest [idcn]
eptifibatide [aapp, phsu]
effective [qlco]
Addition [ftcn]
Currently [tmco]
Available [ftcn]
Therapies [topp]
